Filing Details

Accession Number:
0000908662-15-000280
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-08-06 16:35:22
Reporting Period:
2015-08-04
Filing Date:
2015-08-06
Accepted Time:
2015-08-06 16:35:22
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
907562 Dyax Corp DYAX Services-Commercial Physical & Biological Research (8731) 043053198
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1605767 Todd Bazemore C/O Dyax Corp.
55 Network Drive
Burlington MA 01803-2756
Evp & Chief Commercial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-08-04 33,000 $6.80 33,000 No 4 M Direct
Common Stock Disposition 2015-08-04 33,000 $23.65 0 No 4 S Direct
Common Stock Acquisiton 2015-08-05 10,000 $6.80 10,000 No 4 M Direct
Common Stock Disposition 2015-08-05 10,000 $23.53 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2015-08-04 33,000 $0.00 33,000 $6.80
Common Stock Stock Option (right to buy) Disposition 2015-08-05 10,000 $0.00 10,000 $6.80
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
217,000 2025-02-18 No 4 M Direct
207,000 2025-02-18 No 4 M Direct
Footnotes
  1. The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $23.60 to $23.68, inclusive. The reporting person undertakes to provide to Dyax Corp., any security holder of Dyax Corp., or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 2.
  2. The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $23.50 to $23.645, inclusive. The reporting person undertakes to provide to Dyax Corp., any security holder of Dyax Corp., or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 2.
  3. The option becomes exercisable in forty-eight (48) substantially equal installments at the end of each monthly anniversary of the date of grant, which was April 16, 2014.